The question is: how do we optimize ECS-targeting therapies to treat seizures, pain, neuroprotection, and appetite dysregulation across indications
I have seen some hiccups with prior authorizations, Dr
The POMC and AgRP neurons in the ARC, now under this coordinated regulation, project the integrated signals to downstream regions, such as the PVN [82]
Several newer suppliers have differentiated themselves by publishing comprehensive third-party testing results on their websites, sometimes including raw chromatogram data that more established vendors keep behind customer service requests
Despite this, only a small subset of these systems has yielded approved therapeutics
This three-lever approach has two practical consequences